If you test positive for COVID-19 act fast!

Q: What does this research mean for the field?

Immunocompromised individuals who test positive for COVID-19 should seek monoclonal antibody (mAb) treatment promptly to improve outcomes. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

Jenna E. Reno; Hillary D. Lum; J. Jones; Justin Shrader; Bethany Kwan; Adit Ginde

doi:10.25677/yagd4-ke604

January 1, 2021Open Access

If you test positive for COVID-19 act fast!

View Full Paper

Ask AI

Bookmark

Share

Key Points

To inform immunocompromised individuals about mAb treatment options for COVID-19.
Creation of a flyer containing essential information about mAb treatment.
Targeted communication to immunocompromised individuals.
Updates made to the content in fall 2021.
Provides clarity on what to expect during mAb treatment.
Encourages prompt action upon receiving a positive COVID-19 test result.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

This flyer provides important mAb treatment details for immunocompromised individuals, highlighting the need for quick action upon a positive COVID-19 test.

Abstract

mAb COVID-19 flyer with basic information for people who are immunocompromized about mAb treatment and what to expect during treatment. Last updated fall 2021.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Reno et al. (2021) studied this question.

synapsesocial.com/papers/69b3ac3f02a1e69014ccdba9 https://doi.org/10.25677/yagd4-ke604

View Full Paper

Ask AI

Bookmark

Share

If you test positive for COVID-19 act fast!

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

If you test positive for COVID-19 act fast!

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading